American Cancer Society Urges Prostate Screening From Age 50
The American Cancer Society recommends prostate cancer blood tests every two years for men at average risk, starting at 50. Black men and those with a strong family history should begin annual testing at 45. UK screening advisers have recommended routine checks for a narrower group.

Men at average risk of prostate cancer should have a blood test every two years from age 50 to 69, the American Cancer Society says. Its new guidance also recommends earlier, annual testing for Black men and those with a strong family history.
The US experts said screening can save lives and reduce the risk of a diagnosis after cancer has reached an advanced stage.
The recommendations differ from those of British screening advisers. They have recommended routine testing for a narrower group of men with an inherited genetic fault and a relevant family history.
Professor Andrew Wolf of the University of Virginia chaired the group behind the American Cancer Society’s first guidance update since 2010.
“For the first time, we are making a proactive recommendation for men to screen for prostate cancer with the prostate-specific antigen blood test,” Wolf said.
The test measures prostate-specific antigen, or PSA, a protein made by the prostate. A raised reading can have several causes.
The guidance recommends a second test to check a raised result for men aged 45 to 74. Dr. Robert Smith, the society’s senior vice president for early cancer detection science, said the PSA test is the first step in a screening process.
For men with a strong family history, the society recommends annual checks from age 45. That includes men whose father, brother or son was diagnosed before age 65.
The recommendation also applies when two or more of those relatives developed prostate cancer at any age.
In Britain, the National Screening Committee has recommended tests every two years for men aged 45 to 61 who carry a faulty BRCA2 gene and have a relevant family history.
Officials have said about 1,500 men are currently known to qualify. The committee said wider testing might do more harm than good.
The US experts said medical advances have reduced screening risks. Doctors can better identify who needs a biopsy or treatment and who can safely be monitored, they said.
Prostate cancer is the most commonly diagnosed cancer in the UK. More than 64,000 men are diagnosed each year, and more than 12,000 die from the disease.
Black men are roughly twice as likely to die from prostate cancer as white men.
David James of Prostate Cancer Research said Australian doctors are advised to discuss PSA testing with men aged 50 to 69. Those conversations should start earlier for men at higher risk, he said.
A Department of Health and Social Care spokesperson said the UK screening committee continues to review evidence and consider new research.
The department has begun work on England’s first targeted prostate cancer screening program for men at the highest risk, the spokesperson said. It is also investing more than £30m in prostate cancer research.
Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →- 1Stock Market Today: Dow Slides 1.34% and VIX Jumps 15% at Midday

- 2Joachim Klement to Sell Stocks After S&P 500 Signal

- 3Stock Market Today: Nasdaq, S&P 500 Futures Slide as AI Selloff Deepens

- 4Kenneth Walker’s Groin Injury Puts Cardinals Game in Doubt

- 5Pat Cummins Faces Captaincy Doubts From Mitchell Johnson

Lifestyle · Food & HealthNormal Blood Pressure Chart by Age: Healthy Ranges Explained
Lifestyle · Food & HealthWhat Is Raynaud’s Syndrome? Why Fingers Turn White in the Cold
Lifestyle · Food & Health4 Ways Walking After Meals Helps Your Body, Doctors Say
Lifestyle · Food & Health4 Reasons to Eat Oatmeal, According to Nutrition Experts















